# Sleep Disordered Breathing With Opioid Use

> **NCT05589753** · PHASE1,PHASE2 · RECRUITING · sponsor: **VA Office of Research and Development** · enrollment: 150 (estimated)

## Conditions studied

- Sleep Apnea
- Opioid Use
- Sleep Disordered Breathing

## Interventions

- **OTHER:** Hyperoxia
- **DRUG:** Acetazolamide

## Key facts

- **NCT ID:** NCT05589753
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-05-02
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05589753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05589753, "Sleep Disordered Breathing With Opioid Use". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05589753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*